{
    "2021-01-05": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：国药中生新冠疫苗获批上市 重申看好生物制品中长期投资机会",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "国药中生",
                        "获批上市",
                        "生物制品",
                        "中长期投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药周报：拥抱创新 坚守价值 进一步聚焦结构性机会",
                "features": {
                    "keywords": [
                        "创新",
                        "坚守价值",
                        "结构性机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}